1Institut de Pharmacologie Moléculaire et Cellulaire, UPR 411 du CNRS, Sophia Antipolis, Valbonne, France.
Early-onset Alzheimer's disease (AD) is linked to mutations in presenilins (PS1 and PS2). These mutations increase amyloid-beta (Abeta42) production, contributing to plaque formation and neurodegeneration.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: